Detailseite
Projekt Druckansicht

Beidseitige Katarakt nach einseitiger ultravioletter Bestrahlung. Okulärer Immun-cross-talk und Immunmodulation zwischen linkem und rechtem Auge.

Fachliche Zuordnung Augenheilkunde
Förderung Förderung von 2014 bis 2019
Projektkennung Deutsche Forschungsgemeinschaft (DFG) - Projektnummer 261319924
 
Erstellungsjahr 2019

Zusammenfassung der Projektergebnisse

We demonstrated in our current project that the substance P receptor NKR-1 is not only ubiquitously present in ocular tissues including the lens but that NKR-1 is upregulated after UVR- B exposure in ocular tissues including the retina even though UVR-B does not directly reach the retina since it is absorbed in the lens. Furthermore, we verified our hypothesis that both eyes are connected via a neuropeptide signaling pathway via SP that explains the contralateral involvement after UVR-B exposure of only one eye. This inflammatory reaction can be prevented by the treatment with the NKR-1 antagonist Spantide and the clinical approved drug Fosaprepitant. Thus, we cannot only model physiologic responses to UVR-B on a macroscopic visible, humoural and cellular level, but we even can implement treatment strategies that are already approved for clinical use as in the case of Fosaprepitant in our established experimental model. Recently Bignami et al. demonstrated a growth inhibition of corneal neovascualarizations with Fosaprepitant in a alkali-burn disease model. Based on our findings we seek to continue our current project and further identify UVR- and additionally blue-light induced SP signaling pathways and their involvement in eye diseases such as cataract and age-related macular degeneration in vivo.

Projektbezogene Publikationen (Auswahl)

 
 

Zusatzinformationen

Textvergrößerung und Kontrastanpassung